Seeking Alpha

Cynapsus Therapeutics Inc. (CYNAF)

  • Aug. 13, 2014, 11:04 AM
    • Cynapsus Therapeutics (OTCQX:CYNAF) Q2 results: Revenues: $0; Net Loss: ($2.8M) (-189.4%); Quick Assets: $20.6M (+801.5%).
    • Awarded $500K from Michael J. Fox Foundation for Parkinson's Research on July 8, 2014.
    • No financial guidance given.
    | Aug. 13, 2014, 11:04 AM | Comment!
CYNAF vs. ETF Alternatives
Company Description
Cynapsus is a specialty pharmaceutical company developing a convenient and easy to use sublingual thin filmstrip for the acute rescue of "OFF" motor symptoms of Parkinson's disease.
Sector: Healthcare
Country: Canada